Keysight Technologies has done something unusual in the week after a post-earnings analyst wave: the stock has actually followed the upgrades higher, with price and positioning now moving in the same direction.
The most notable development this week is the continuation of the analyst reset that began immediately after May 19 earnings. Last week's note flagged the breadth of the target raises — this week, the market is validating them. The stock gained 3.4% on the week to close at $355.74, recovering the ground lost in the immediate post-print selloff. The consensus mean target has moved to $383, implying roughly 8% upside from here. JP Morgan, maintaining Overweight, pushed its target to $390. Citi, at Buy, went to $396. Truist, the lone Hold in the recent wave, nonetheless raised its target from $310 to $376 — a 21% lift on a neutral rating, which itself signals how dramatically the earnings print changed the fundamental view. Morgan Stanley's equal-weight target of $350 now looks like the Street's floor rather than a contrarian call.
Options positioning has swung to match. The put/call ratio has dropped to 0.775, running nearly 1.4 standard deviations below its 20-day average of 1.03. That is a sharp reversal from the defensive posture that characterised most of April and early May, when the PCR sat persistently above 1.10. Calls now dominate the open interest mix, consistent with a market that has shifted from hedging a downside risk into positioning for further upside. The 52-week PCR low was 0.615, hit on May 19 — the day of the print — so current readings remain elevated versus that immediate spike, but the directional move is unmistakable.
Short interest tells a quieter story and does not warrant much attention at this price level. Estimated shorts amount to just 1.3% of the free float — a low reading that ticked up roughly 4% on the week to around 2.3 million shares, but at these levels the absolute quantum is modest. Borrowing costs have fallen sharply, down 33% on the week to 0.29%, and availability remains extremely loose at over 8,000% of short interest. There is no squeeze pressure in the lending market and no structural short overhang to unwind.
The factor picture is mixed in a way that fits the post-earnings recovery narrative. EPS momentum scores are strong — 82nd percentile over 30 days and 73rd over 90 — reflecting the recent beat and the string of upward revisions to forward estimates. The short score ranks in the 84th percentile, though that reads more as a signal of positioning dynamics than fundamental distress given the 1.3% float figure. EV/EBIT sits in the 20th percentile, suggesting the valuation has been re-rated but remains demanding on an earnings-power basis. The trailing P/E has drifted down about 3.6 points over the past month to 32.8x — a modest decompression as earnings expectations caught up with the price.
Insider activity does not add much new signal this week. CEO Satish Dhanasekaran sold 500 shares on May 18 at $340.48, a minor transaction carrying the lowest possible significance score. The heavier selling cluster was back in late March — the CEO, CFO, and General Counsel all sold in the $275–$300 range — which now looks like routine plan-driven selling ahead of what turned out to be a strong earnings quarter.
Among close peers, GLW gained 9.9% on the week and AEIS rose nearly 10%, with KN up 10.7%. Keysight's 3.4% gain lagged the peer group's move, which suggests the broad electronic instruments sector caught a tailwind this week beyond the Keysight-specific earnings catalyst. Whether KEYS closes that performance gap — or whether the peer surge was driven by separate factors — is worth watching as the week's positioning settles.
The stock has no confirmed next earnings event in the data. With the post-print revision wave now largely digested, the near-term question narrows to whether the demand recovery in semiconductor and 5G test equipment that management flagged actually materialises in the fiscal Q3 order book.
See the live data behind this article on ORTEX.
Open KEYS on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
